Latest Financial Markets News

Yowie Group has lodged a formal application with the Takeovers Panel to block Keybridge Capital from convening a shareholder meeting aimed at replacing Yowie’s board, accusing Keybridge of trying to frustrate its takeover offer.

Auric Mining Ltd has unveiled a capital raising plan aimed at boosting gold production and expanding its resource base through 2028, including key acquisitions and exploration initiatives.

Tower Limited reported a robust half year profit for 2025, driven by improved claims performance and premium growth in its home insurance portfolio, despite ongoing challenges from Canterbury earthquake claims and competitive motor insurance pricing.

QBE Insurance Group has announced plans to issue AUD subordinated notes as part of its capital management strategy, aiming to strengthen its Tier 2 capital base. Details on pricing and timing will follow, contingent on market conditions.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7124 per security on its perpetual capital notes, with a 35% franking rate and a total distribution yield of 6.79% per annum.

Macquarie Bank Limited reported an 18% rise in net profit for FY2025, driven by growth in its retail banking segment despite margin pressures, while its commodities business faced subdued markets. The bank maintained strong capital ratios and advanced its risk and technology frameworks amid regulatory scrutiny.

Macquarie Group reported a 5% rise in full-year net profit to A$3.715 billion for FY25, driven by growth across its diversified businesses and a solid capital position. The group’s assets under management reached A$941 billion, supported by strong home loan and deposit growth.

Macquarie Group reported a 5% increase in full-year net profit to A$3.7 billion for FY25, driven by strong second-half growth and robust asset management performance. The company declared a final dividend of A$3.90 per share and extended its share buyback program.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy by executing three CAR-T term sheets and completing technical due diligence, while implementing cost-cutting measures and seeking new capital amid a tough financing environment.

EverGreen Lithium’s 2024 drilling at the Bynoe Project confirms anomalous gold mineralisation but no significant lithium, prompting a strategic pivot to expanded gold and pegmatite exploration in 2025.

Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.

Omni Bridgeway reports robust investment performance for FY25, highlighted by record proceeds and a landmark Fund 9 transaction that strengthens its balance sheet and strategic position.